Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by Dcowboy31on Dec 01, 2017 3:18pm

47 Views

Post# 27074610

RE:3,900,000 shares diluted and you think it'll rise

Eplexx420 wrote: New age gave 3,900,000 million shares out at 9 1/2 cents and you want to believe this stock will keep going up for what reason? Once these shares expire then you'll see a big rise just like last time shares expired.

Are you being serious? That's only 3% of the shares

Bullboard Posts

Rig Count Soars as Utilization Surpasses Industry Averages